series-c-plus
Stage
3
Investors
About
PIC Therapeutics is a biotechnology company focused on developing small molecule therapeutics that target the pre-initiation complex (PIC) to modulate RNA translation and treat cancer by addressing drug resistance and tumor heterogeneity.
Explore PIC Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.